CO4600671A1 - Formulacion de cafeina de liberacion sostenida - Google Patents
Formulacion de cafeina de liberacion sostenidaInfo
- Publication number
- CO4600671A1 CO4600671A1 CO95059167A CO95059167A CO4600671A1 CO 4600671 A1 CO4600671 A1 CO 4600671A1 CO 95059167 A CO95059167 A CO 95059167A CO 95059167 A CO95059167 A CO 95059167A CO 4600671 A1 CO4600671 A1 CO 4600671A1
- Authority
- CO
- Colombia
- Prior art keywords
- stimulant
- sustained release
- compound
- release caffeine
- caffeine formulation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Abstract
UN COMPUESTO PARA LA LIBERACION DE UN ESTIMULANTE DE XANTINA O UN DERIVADO DE XANTINA, EL CUAL COM- PRENDE MICROPARTICULAS QUE INCLUYEN UNA MATRIZ BIODEGRADABLE DE POR LO MENOS UN MATERIAL SOLUBLE EN AGUA Y EL ESTIMULANTE, DICHO ESTIMULANTE ES EN FORMA DE PARTICULAS SOLIDAS QUE ESTAN SUSTANCIAL- MENTE DISTRIBUIDAS EN FORMA UNIFORME EN TODA LA MATRIZ. UN METODO PARA HACER UN COMPUESTO PARA LA LIBERA- CION CONTROLADA DE UN ESTIMULANTE DE ACUERDO CON LA REIVINDICACION 1, EL CUAL COMPRENDE DISPERSAR UN ESTIMULANTE EN LA FORMA DE UNA PLURALIDAD DE PARTICULAS SOLIDAS EN UNA MATRIZ BIODEGRADABLE. FIGURA 1
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/357,689 US5744164A (en) | 1994-12-16 | 1994-12-16 | Sustained release microparticulate caffeine formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
CO4600671A1 true CO4600671A1 (es) | 1998-05-08 |
Family
ID=23406640
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO95059167A CO4600671A1 (es) | 1994-12-16 | 1995-12-14 | Formulacion de cafeina de liberacion sostenida |
Country Status (21)
Country | Link |
---|---|
US (2) | US5744164A (es) |
EP (2) | EP0716853A1 (es) |
JP (1) | JPH10510529A (es) |
AR (1) | AR002947A1 (es) |
AT (1) | ATE201986T1 (es) |
AU (1) | AU694810B2 (es) |
CA (1) | CA2208149C (es) |
CO (1) | CO4600671A1 (es) |
DE (1) | DE69521328T2 (es) |
DK (1) | DK0789562T3 (es) |
ES (1) | ES2158956T3 (es) |
GR (1) | GR3036501T3 (es) |
HK (1) | HK1000878A1 (es) |
IL (1) | IL116066A (es) |
NZ (1) | NZ295245A (es) |
PE (1) | PE55396A1 (es) |
PT (1) | PT789562E (es) |
RU (1) | RU2144353C1 (es) |
TR (1) | TR199501560A2 (es) |
WO (1) | WO1996018389A1 (es) |
ZA (1) | ZA9510687B (es) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0833617A1 (en) * | 1995-06-20 | 1998-04-08 | Pharma-Vinci A/S | A method of preparing an oral preparation provided on the outer side with an enteric coating, as well as an oral preparation obtained by the method |
US6627234B1 (en) | 1998-12-15 | 2003-09-30 | Wm. Wrigley Jr. Company | Method of producing active agent coated chewing gum products |
US6531114B1 (en) | 1999-04-06 | 2003-03-11 | Wm. Wrigley Jr. Company | Sildenafil citrate chewing gum formulations and methods of using the same |
US7163705B2 (en) * | 1998-12-15 | 2007-01-16 | Wm. Wrigley Jr. Company | Coated chewing gum product and method of making |
US6586023B1 (en) | 1998-12-15 | 2003-07-01 | Wm. Wrigley Jr. Company | Process for controlling release of active agents from a chewing gum coating and product thereof |
US6322806B1 (en) | 1999-04-06 | 2001-11-27 | Wm. Wrigley Jr. Company | Over-coated chewing gum formulations including tableted center |
US6355265B1 (en) | 1999-04-06 | 2002-03-12 | Wm. Wrigley Jr. Company | Over-coated chewing gum formulations |
US20020159956A1 (en) * | 1999-04-06 | 2002-10-31 | Ream Ronald L. | Over-coated chewing gum formulations |
US7935362B2 (en) * | 1999-04-06 | 2011-05-03 | Wm. Wrigley Jr. Company | Over-coated product including consumable center and medicament |
US6773716B2 (en) | 1999-04-06 | 2004-08-10 | Wm. Wrigley Jr. Company | Over-coated chewing gum formulations |
US6426090B1 (en) * | 1999-04-06 | 2002-07-30 | Wm. Wrigley Jr. Company | Over-coated product including tableted center and medicament |
US6569472B1 (en) | 2000-09-01 | 2003-05-27 | Wm. Wrigley Jr. Company | Coated chewing gum products containing antacid and method of making |
US6663849B1 (en) | 2000-09-01 | 2003-12-16 | Wm. Wrigley Jr. Company | Antacid chewing gum products coated with high viscosity materials |
US6541048B2 (en) | 1999-09-02 | 2003-04-01 | Wm. Wrigley Jr. Company | Coated chewing gum products containing an acid blocker and process of preparing |
US6645535B2 (en) | 1999-09-02 | 2003-11-11 | Wm. Wrigley Jr. Company | Method of making coated chewing gum products containing various antacids |
US9253991B2 (en) | 1999-09-20 | 2016-02-09 | Jack Barreca | Chewing gum with B vitamins |
WO2001021147A1 (en) * | 1999-09-20 | 2001-03-29 | Mastercare | Diet and weight control gum and sucker |
US9387168B2 (en) | 1999-09-20 | 2016-07-12 | Jack Barreca | Chewing gum with tomatidine |
US7115297B2 (en) | 2000-02-22 | 2006-10-03 | Suzanne Jaffe Stillman | Nutritionally fortified liquid composition with added value delivery systems/elements/additives |
US7892586B2 (en) | 2001-02-22 | 2011-02-22 | Suzanne Jaffe Stillman | Water containing soluble fiber |
US8178150B2 (en) | 2000-02-22 | 2012-05-15 | Suzanne Jaffe Stillman | Water containing soluble fiber |
US7115288B2 (en) * | 2000-06-09 | 2006-10-03 | Wm. Wrigley Jr. Company | Method for making coated chewing gum products with a coating including an aldehyde flavor and a dipeptide sweetener |
US6572900B1 (en) | 2000-06-09 | 2003-06-03 | Wm. Wrigley, Jr. Company | Method for making coated chewing gum products including a high-intensity sweetener |
US6444241B1 (en) | 2000-08-30 | 2002-09-03 | Wm. Wrigley Jr. Company | Caffeine coated chewing gum product and process of making |
US6579545B2 (en) | 2000-12-22 | 2003-06-17 | Wm. Wrigley Jr. Company | Coated chewing gum products containing an antigas agent |
US7897141B2 (en) * | 2002-04-01 | 2011-03-01 | Drexel University | Echogenic polymer microcapsules and nanocapsules and methods for production and use thereof |
US20030220351A1 (en) * | 2002-05-24 | 2003-11-27 | Gilbert Gonzales | Enteric coated caffeine tablet |
EP1565062A1 (en) * | 2002-11-25 | 2005-08-24 | Phares Pharmaceutical Research N.V. | Confectionery composition |
US20050181044A1 (en) * | 2004-02-18 | 2005-08-18 | Jaime Romero | Compositions and methods for timed release of water-soluble nutritional supplements, green coffee extract |
US20050220875A1 (en) * | 2004-03-31 | 2005-10-06 | Agency For Science, Technology And Research | Sustained-release tablet formulation |
FR2883179B1 (fr) | 2005-03-18 | 2009-04-17 | Ethypharm Sa | Comprime enrobe |
US8486452B2 (en) | 2007-07-20 | 2013-07-16 | Mylan Pharmaceuticals Inc. | Stabilized tolterodine tartrate formulations |
US8110226B2 (en) * | 2007-07-20 | 2012-02-07 | Mylan Pharmaceuticals Inc. | Drug formulations having inert sealed cores |
US8044021B2 (en) * | 2007-09-20 | 2011-10-25 | Abbott Cardiovascular Systems Inc. | Sustained release of apo A-I mimetic peptides and methods of treatment |
US7985727B1 (en) | 2007-09-20 | 2011-07-26 | Abbott Cardiovascular Systems Inc. | Apo A-I mimetic peptides and methods of treatment |
US8101565B2 (en) * | 2007-09-20 | 2012-01-24 | Abbott Cardiovascular Systems Inc. | Sustained release of Apo A-I mimetic peptides and methods of treatment |
US9173890B2 (en) * | 2007-09-20 | 2015-11-03 | Abbott Cardiovascular Systems Inc. | Sustained release of Apo A-I mimetic peptides and methods of treatment |
US7985728B1 (en) | 2007-09-20 | 2011-07-26 | Abbott Cardiovascular Systems Inc. | Sustained release of Apo A-I mimetic peptides and methods of treatment |
JP2012515765A (ja) * | 2009-01-22 | 2012-07-12 | アボット ヘルスケア プライベート リミテッド | 時間治療用医薬組成物 |
US8545892B2 (en) * | 2009-06-26 | 2013-10-01 | Nano Pharmaceutical Laboratories, Llc | Sustained release beads and suspensions including the same for sustained delivery of active ingredients |
US8992898B2 (en) | 2010-04-17 | 2015-03-31 | Shannon Elizabeth Klingman | Antiperspirants and deodorants |
WO2014197601A1 (en) * | 2013-06-04 | 2014-12-11 | KVK-Tech, Inc. | Controlled release caffeine dosage forms |
BR112017014953A2 (pt) | 2015-01-12 | 2018-03-13 | Nano Pharmaceutical Laboratories Llc | microglóbulos de liberação controlada em camadas e métodos para produção dos mesmos |
KR101644154B1 (ko) * | 2015-09-08 | 2016-07-29 | 주식회사 스킨앤테크 | 수용성 카페인 및 그 제조방법 |
US10582716B1 (en) | 2019-06-14 | 2020-03-10 | Lennham Pharmaceuticals, Inc. | Deuterated caffeine and uses thereof |
US20220288083A1 (en) * | 2021-03-09 | 2022-09-15 | Lennham Pharmaceuticals, Inc. | D9-caffeine compositions and uses thereof |
WO2023004733A1 (zh) * | 2021-07-30 | 2023-02-02 | 宝龄富锦生技股份有限公司 | 控制释放口服制剂及其制备方法 |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3265629A (en) * | 1958-12-22 | 1966-08-09 | Ncr Co | Coating by phase separation |
DE1249219B (de) * | 1958-12-22 | 1967-09-07 | The National Cash Register Company, Dayton, Ohio (V. St. A.) | Herstellen von Mikrokapseln, die eine Emulsion aus Öl in hydrophiler Flüssigkeit enthalten |
DE2010416B2 (de) * | 1970-03-05 | 1979-03-29 | Hoechst Ag, 6000 Frankfurt | Oral anwendbare Arzneiform mit Retardwirkung |
US4001480A (en) * | 1974-08-16 | 1977-01-04 | Swift & Company | Encapsulation process utilizing microorganisms and products produced thereby |
IE55745B1 (en) * | 1983-04-06 | 1991-01-02 | Elan Corp Plc | Sustained absorption pharmaceutical composition |
EP0185127B1 (fr) * | 1983-06-24 | 1988-09-21 | Dridrinks N.V. | Procédé de traitement d'acides utilisés comme constituants d'une composition pulvérulente hydrosoluble pour boissons à dégagement gazeux prolongé |
NZ207813A (en) * | 1983-06-24 | 1986-12-05 | Dridrinks Nv | Effervescent mixture:component(s)coated with water-soluble polysaccharide composition |
NZ210785A (en) * | 1984-01-13 | 1987-11-27 | Battelle Development Corp | Liquid dispersions of layered controlled release dosage forms |
DE3403329A1 (de) * | 1984-02-01 | 1985-08-01 | Horst Dr. 4019 Monheim Zerbe | Pharmazeutisches produkt in form von pellets mit kontinuierlicher, verzoegerter wirkstoffabgabe |
AU571312B2 (en) * | 1984-02-10 | 1988-04-14 | Nycomed Danmark A/S | Diffusion coated multiple-units dosage form |
DK62184D0 (da) * | 1984-02-10 | 1984-02-10 | Benzon As Alfred | Diffusionsovertrukket polydepotpraeparat |
NL8500724A (nl) * | 1985-03-13 | 1986-10-01 | Univ Groningen | Inrichtingen voor geregelde afgifte van werkzame stoffen, alsmede werkwijze ter vervaardiging daarvan. |
DE3537770A1 (de) * | 1985-10-24 | 1987-04-30 | Basf Ag | Salze mehrwertiger kationen von polymerisaten von konjugierten dienen |
US4853249A (en) * | 1985-11-15 | 1989-08-01 | Taisho Pharmaceutical Co., Ltd. | Method of preparing sustained-release pharmaceutical/preparation |
AU7280387A (en) * | 1986-04-07 | 1987-11-09 | Rorer International (Overseas) Inc. | Method for the preparation of a sustained release pharmaceutical composition and the compostion prepared thereby |
US5026709A (en) * | 1986-04-07 | 1991-06-25 | Rorer Pharmaceutical Corporation | Method for the preparation of a theophylline sustained release pharmaceutical composition and the composition prepared thereby |
GB8613689D0 (en) * | 1986-06-05 | 1986-07-09 | Euro Celtique Sa | Pharmaceutical composition |
US5200193A (en) * | 1987-04-22 | 1993-04-06 | Mcneilab, Inc. | Pharmaceutical sustained release matrix and process |
JP2643222B2 (ja) * | 1988-02-03 | 1997-08-20 | エーザイ株式会社 | 多重層顆粒 |
US4971785A (en) * | 1988-03-14 | 1990-11-20 | Spectrum Consumer Products Co., Inc. | Non-alcoholic delivery system for orally ingestible active ingredients |
US5202128A (en) * | 1989-01-06 | 1993-04-13 | F. H. Faulding & Co. Limited | Sustained release pharmaceutical composition |
CA2007181C (en) * | 1989-01-06 | 1998-11-24 | Angelo Mario Morella | Sustained release pharmaceutical composition |
US5330766A (en) * | 1989-01-06 | 1994-07-19 | F. H. Faulding & Co. Limited | Sustained release pharmaceutical composition |
JPH06316517A (ja) * | 1993-02-22 | 1994-11-15 | Grelan Pharmaceut Co Ltd | 放出制御製剤 |
-
1994
- 1994-12-16 US US08/357,689 patent/US5744164A/en not_active Expired - Lifetime
-
1995
- 1995-03-17 EP EP95103931A patent/EP0716853A1/en not_active Withdrawn
- 1995-11-20 IL IL11606695A patent/IL116066A/xx not_active IP Right Cessation
- 1995-11-27 DE DE69521328T patent/DE69521328T2/de not_active Expired - Lifetime
- 1995-11-27 RU RU97111886A patent/RU2144353C1/ru active
- 1995-11-27 JP JP8518527A patent/JPH10510529A/ja active Pending
- 1995-11-27 ES ES95936707T patent/ES2158956T3/es not_active Expired - Lifetime
- 1995-11-27 WO PCT/IB1995/001056 patent/WO1996018389A1/en active IP Right Grant
- 1995-11-27 NZ NZ295245A patent/NZ295245A/xx not_active IP Right Cessation
- 1995-11-27 DK DK95936707T patent/DK0789562T3/da active
- 1995-11-27 AU AU38542/95A patent/AU694810B2/en not_active Expired
- 1995-11-27 CA CA002208149A patent/CA2208149C/en not_active Expired - Lifetime
- 1995-11-27 AT AT95936707T patent/ATE201986T1/de active
- 1995-11-27 PT PT95936707T patent/PT789562E/pt unknown
- 1995-11-27 EP EP95936707A patent/EP0789562B1/en not_active Expired - Lifetime
- 1995-12-05 PE PE1995286458A patent/PE55396A1/es not_active Application Discontinuation
- 1995-12-11 AR ARP950100500A patent/AR002947A1/es unknown
- 1995-12-12 TR TR95/01560A patent/TR199501560A2/xx unknown
- 1995-12-14 CO CO95059167A patent/CO4600671A1/es unknown
- 1995-12-15 ZA ZA9510687A patent/ZA9510687B/xx unknown
-
1996
- 1996-08-16 US US08/698,621 patent/US5700484A/en not_active Expired - Lifetime
-
1997
- 1997-12-23 HK HK97102557A patent/HK1000878A1/xx not_active IP Right Cessation
-
2001
- 2001-08-31 GR GR20010401361T patent/GR3036501T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
CA2208149A1 (en) | 1996-06-20 |
DE69521328D1 (de) | 2001-07-19 |
WO1996018389A1 (en) | 1996-06-20 |
AR002947A1 (es) | 1998-05-27 |
ZA9510687B (en) | 1996-07-03 |
PT789562E (pt) | 2001-10-30 |
AU3854295A (en) | 1996-07-03 |
US5744164A (en) | 1998-04-28 |
CA2208149C (en) | 2007-03-27 |
NZ295245A (en) | 1999-01-28 |
GR3036501T3 (en) | 2001-11-30 |
DE69521328T2 (de) | 2002-01-17 |
RU2144353C1 (ru) | 2000-01-20 |
AU694810B2 (en) | 1998-07-30 |
EP0716853A1 (en) | 1996-06-19 |
ES2158956T3 (es) | 2001-09-16 |
IL116066A0 (en) | 1996-01-31 |
IL116066A (en) | 2000-10-31 |
TR199501560A2 (tr) | 1996-07-21 |
US5700484A (en) | 1997-12-23 |
ATE201986T1 (de) | 2001-06-15 |
EP0789562A1 (en) | 1997-08-20 |
EP0789562B1 (en) | 2001-06-13 |
JPH10510529A (ja) | 1998-10-13 |
DK0789562T3 (da) | 2001-09-03 |
HK1000878A1 (en) | 2001-10-26 |
PE55396A1 (es) | 1996-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO4600671A1 (es) | Formulacion de cafeina de liberacion sostenida | |
EP0595030A3 (en) | Composition of microspheres with several delayed release nuclei and its preparation process. | |
ES2072967T3 (es) | Particulas de perfume revestidas. | |
ES2045906T3 (es) | Estructuras de liberacion gradual para goma de mascar. | |
ES2062563T3 (es) | Procedimiento para preparar un solido hidrofobo o aerofilo dispersable en agua. | |
ES2177022T3 (es) | Un itraconazol que exhibe una solubilidad mejorada, un metodo para preparar el mismo y una composicion farmaceutica para administracion oral que comprende el mismo. | |
EP0361936A3 (en) | Lasing compositions and methods for using the same | |
BR9301317A (pt) | Esponja heteromorfica bioabsorvivel e metodo para sua obtencao | |
DE69816997D1 (de) | Mittel, die fein verteilte, kristalline budenosid-partikel enthalten | |
ATE378059T1 (de) | Pharmazeutische zusammensetzungen mit verzoegerter freisetzung, die wasserunloesliche komplexverbindungen enthalten | |
AR002364A1 (es) | Método para proporcionar por lo menos una fuerza estabilizadora un un cojinete magnético y estructura para cojinetes magnéticos producida mediante el método | |
PT904063E (pt) | Processo para a preparacao de microparticulas | |
NL191829B (nl) | Kunsthaar voor haarimplantatie, alsmede werkwijze voor het vervaardigen daarvan en inrichting voor het uitvoeren van deze werkwijze. | |
ES2062137T3 (es) | Utilizacion de 5'-deoxi-5'-metil-tioadenosina, s-adenosilmetionina y sus sales para la preparacion de composiciones farmaceuticas reductoras de seborrea. | |
DK0414115T3 (da) | Hjælpemiddelfrie riboflavingranulater | |
BR9802621B1 (pt) | mÉtodo para a produÇço de um prÉ-impregnado e uso de um prÉ-impregnado. | |
MX9202437A (es) | Metodo para la preparacion de matriz de hidrogel de poliuretano y producto obtenido mediante el mismo. | |
ECSP951592A (es) | Formulacion de cafeina de liberacion sostenida | |
DE69002820T2 (de) | Tandembremskraftverstärker und Hauptzylinderaufbau. | |
IT229944Y1 (it) | Matrici riutilizzabili per cornicioni e parti decorative. realizzate in polistirolo espanso ricoperte nella parte sagomata di materiale | |
ID27965A (id) | Turunan-turunan asam karboksilik baru yang membawa rantai sisi keto, dan pembuatannya dan penggunaan sebagai antagonis reseptor endotelin | |
IT8811792V0 (it) | Modello per la realizzazione di forme di fusione in terra per la produzione di chiusini | |
IL141682A0 (en) | Process for the production of microparticles using a water-immiscible organic solvent, and a sustained release formulation comprising said microparticles | |
ES1010587Y (es) | Disposicion perfeccionada para la instalacion de jambas en puertas y similares. | |
ES1027098Y (es) | Rejilla perfeccionada para pavimentos y similares. |